Delivery Order SPE2DB22D2206-SPE2DB24FJC12

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $98K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $13,899.39 and a period of performance through February 7, 2024. The contract is a firm fixed price delivery order type and was not set aside for any specific business category. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $31,327.60 and a period of performance through March 24, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, with a ceiling value of $4,651.92 and a period of performance through May 13, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $33,017.82 and a completion date of May 21, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a firm fixed price, with a ceiling value of $6,743.48, and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication JARDIANCE 25 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $3,658.03 and a period of performance through May 29, 2025. The contract is not set aside and is awarded as part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $16,647.60 and a period of performance through March 19, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a firm fixed price pricing type, a ceiling value of $27,597.87, and a period of performance through May 16, 2025. The contract is not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $11,862.03 and a completion date of January 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 10 MG TABLET 90S. The contract has a ceiling value of $4,821.21 and runs through December 2, 2022. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and valid through November 2026. This IDC serves as the primary vehicle for...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJC12
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $98,109.09 and runs through July 9, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:12 AM